Protagenic Therapeutics, Inc.\new Book Value Per Share Growth & History (PTIX)

Protagenic Therapeutics, Inc.\new's book value per share was $1.45 for fiscal 2026.

View full Protagenic Therapeutics, Inc.\new company overview

Protagenic Therapeutics, Inc.\new annual book value per share history

Protagenic Therapeutics, Inc.\new annual book value per share

Fiscal yearPeriod endedBook value per shareChangeGrowth
20262026-03-31$1.45$2.30
20252025-03-31-$0.85
20242024-12-31-$6.41-$17.99
20232023-12-31$11.58-$10.83−48.33%
20222022-12-31$22.41-$9.94−30.73%
20212021-12-31$32.35$38.57
20202020-12-31-$6.21-$2.75
20192019-12-31-$3.46-$2.31
20182018-12-31-$1.15-$7.81
20172017-12-31$6.65-$6.87−50.80%
20162016-12-31$13.52$19.22
2015 · Dec 312015-12-31-$5.69
2015 · Jun 302015-06-30-$0.07-$0.07
20142014-06-30-$0.00

Protagenic Therapeutics, Inc.\new book value per share trends

Between the periods ended 2014-06-30 and 2026-03-31, Protagenic Therapeutics, Inc.\new's book value per share increased from -$0.00 to $1.45, a change of $1.45. The latest reported quarter, Q1 2027, shows $0.95.

About the metric

What book value per share means

Book value per share estimates the common shareholders’ accounting equity represented by each share. It can help compare a company’s balance-sheet value over time, although market value can differ substantially from book value.

Calculation and source

How book value per share is calculated

TickerStat calculates book value per share as SEC-reported common shareholders’ equity divided by reported period-end common shares. Preferred equity is subtracted when separately reported, and basic weighted-average shares are used only when period-end shares are unavailable. Fiscal periods can differ from calendar years, so exact period-end dates are included.

Review Protagenic Therapeutics, Inc.\new source filings ↗

Community posts

It’s quiet here.

No posts about PTIX yet. Start the conversation.

Write the first post